Classes
Publications
- 10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group2013 | Central Library of Charles University
- Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide2011 | Faculty of Medicine in Hradec Králové
- Low-dose thalidomid in refractory and relapsing multiple myeloma +12007 | Faculty of Medicine in Hradec Králové
- Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatment +12007 | Faculty of Medicine in Hradec Králové
- Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatment2007 | Publication without faculty affiliation
- Successful treatment of anemia and trombocytopenia with Thalidomide and Prednison in idiopatic myelofibrosis2006 | Publication without faculty affiliation
- Nízkodávkovaný Thalidomid v léčbě refrakterního a relabujícího mnohočetného myelomuPublication without faculty affiliation
- Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Standardized 18F-FDG PET/CT in patients with myeloma: joint recommendation of Czech Myeloma Group and Czech Society of Nuclear Medicine2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
Loading network view...